Home Cart Sign in  
Chemical Structure| 10405-02-4 Chemical Structure| 10405-02-4

Structure of Trospium chloride
CAS No.: 10405-02-4

Chemical Structure| 10405-02-4

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Trospium chloride is a competitive antagonist at muscarinic cholinergic receptors, used to treat symptoms of an overactive bladder.

Synonyms: Trospium (chloride); Relaspium

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Trospium chloride

CAS No. :10405-02-4
Formula : C25H30ClNO3
M.W : 427.96
SMILES Code : OC(C1=CC=CC=C1)(C2=CC=CC=C2)C(O[C@@H]3C[C@@]4([H])[N@@+]5(CCCC5)[C@@](CC4)([H])C3)=O.[Cl-]
Synonyms :
Trospium (chloride); Relaspium
MDL No. :MFCD00865254
InChI Key :RVCSYOQWLPPAOA-DHWZJIOFSA-M
Pubchem ID :5284631

Safety of Trospium chloride

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Isoform Comparison

Biological Activity

Target
  • AChR

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT02386072 - Completed - -
NCT00547378 Urinary Incontinence, Urgency-... More >>frequency Overactive Bladder Less << Phase 4 Completed - -
NCT01499069 Overactive Bladder Not Applicable Unknown December 2015 Korea, Republic of ... More >> Samsung Medical Center Recruiting Seoul, Korea, Republic of, 135-710 Contact: Kyu-Sung Lee, Ph.D    82-2-3410-3554    ksleedr@skku.edu    Contact: Bong-Hee Lim, BA    82-2-3410-3743    bonghee.lim@sbri.co.kr    Sub-Investigator: Deok Hyun Han, PhD          Sub-Investigator: Young-Suk Lee, PhD          Sub-Investigator: Ha Na Lee, PhD Less <<
NCT00547378 - Completed - -
NCT03602508 - Active, not recruiting February 2019 Australia ... More >> Site AU10000 Sydney, Australia Korea, Republic of Site KR82001 Seoul, Korea, Republic of Less <<
NCT01166438 Urge Urinary Incontinence ... More >> Overactive Bladder Less << Phase 3 Completed - United States, Alabama ... More >> The University of Alabama at Birmingham Birmingham, Alabama, United States, 35249 United States, California USCD Medical Center La Jolla, California, United States, 92037 Kaiser Permanente San Diego, California, United States, 92037 United States, Illinois Loyola University Medical Center Maywood, Illinois, United States, 60153 United States, Michigan Oakwood Hospital Dearborn, Michigan, United States, 48124 Beaumont Hospital Royal Oak, Michigan, United States, 48073 United States, North Carolina Duke University Durham, North Carolina, United States, 27710 United States, Ohio Cleveland Clinic Cleveland, Ohio, United States, 44195 United States, Pennsylvania Magee-Women's Hospital Pittsburgh, Pennsylvania, United States, 15213 United States, Texas University of Texas Southwestern Medical Center Dallas, Texas, United States, 75390 United States, Utah University of Utah Salt Lake City, Utah, United States, 84132 Less <<
NCT00800462 Spinal Cord Injury ... More >> Neurogenic Detrusor Overactivity Less << Phase 4 Completed - Canada, Manitoba ... More >> University of Manitoba, Health Sciences Centre Winnipeg, Manitoba, Canada, R3A1R9 Canada, Ontario Toronto Rehabilitation Institute, Lyndhurst Centre Toronto, Ontario, Canada, M4G 3V9 Less <<
NCT01166438 - Completed - -
NCT03697252 Schizophrenia Phase 2 Recruiting November 5, 2019 United States, Arkansas ... More >> Woodland International Research Group, LLC Recruiting Little Rock, Arkansas, United States, 72211 United States, California Synergy East Recruiting Lemon Grove, California, United States, 91945 Collaborative Neuroscience Network, LLC. Recruiting Long Beach, California, United States, 90806 NRC Research Institute Recruiting Orange, California, United States, 92868 Artemis Institute for Clinical Research Recruiting San Diego, California, United States, 92103 United States, Georgia Atlanta Center for Medical Research Recruiting Atlanta, Georgia, United States, 30331 United States, Maryland CBH Health, LLC Recruiting Gaithersburg, Maryland, United States, 20877 United States, New Jersey Hassman Research Institute Recruiting Berlin, New Jersey, United States, 08009 United States, Ohio Midwest Clinical Research Center (and IP Shipment) Recruiting Dayton, Ohio, United States, 45417 United States, Texas Community Clinical Research, Inc. Recruiting Austin, Texas, United States, 78754 InSite Clinical Research, LLC Recruiting DeSoto, Texas, United States, 75115 Pillar Clinical Research, LLC Recruiting Richardson, Texas, United States, 75080 Less <<
NCT03109379 Idiopathic Overactive Bladder ... More >>With Urinary Incontinence Less << Phase 1 Active, not recruiting June 30, 2018 United States, Michigan ... More >> William Beaumont Hospital - Royal Oak Royal Oak, Michigan, United States, 48073 Michigan Institute of Urology Troy, Michigan, United States, 48084 United States, New York Accumed Research Garden City, New York, United States, 11530-1664 United States, Virginia Urology of Virginia Virginia Beach, Virginia, United States, 23462 Less <<
NCT03572231 - Recruiting December 2019 Korea, Republic of ... More >> Site KR410008 Recruiting Daejeon, Korea, Republic of Site KR410009 Recruiting Incheon, Korea, Republic of Site KR410001 Recruiting Seoul, Korea, Republic of Site KR410003 Recruiting Seoul, Korea, Republic of Site KR410006 Recruiting Seoul, Korea, Republic of Taiwan Site TW158001 Recruiting Hualien City, Taiwan Less <<
NCT00465959 Chronic Obstructive Pulmonary ... More >>Disease Less << Phase 1 Phase 2 Completed - United States, South Carolina ... More >> United States Investigational Site Spartanburg, South Carolina, United States Less <<
NCT00801684 Chronic Obstructive Pulmonary ... More >>Disease (COPD) Less << Phase 2 Completed - United States, South Carolina ... More >> Spartanburg Medical Research Spartanburg, South Carolina, United States, 29303 Less <<
NCT03011463 Pharmacokinetics ... More >> Inhibition Enzyme Drug Interaction Potentiation Less << Phase 1 Completed - -
NCT03168828 Neurogenic Detrusor Overactivi... More >>ty Less << Phase 1 Active, not recruiting September 30, 2018 United States, Michigan ... More >> Michigan Institute of Urology Troy, Michigan, United States, 48084 United States, North Carolina Carolinas HealthCare System Charlotte, North Carolina, United States, 28207 United States, Virginia Urology of Virginia Virginia Beach, Virginia, United States, 23462 United States, Washington Virginia Mason Seattle, Washington, United States, 98101 Less <<
NCT00801684 - Completed - -
NCT01922115 Mental Competency ... More >> Urinary Bladder, Overactive Cognitive Function Less << Phase 4 Completed - United States, North Carolina ... More >> Unc Chapel Hill Urogynecology A2 Clinic Chapel Hill, North Carolina, United States, 27517 Less <<
NCT01178827 - Completed - -
NCT01922115 - Completed - -
NCT01178827 Overactive Bladder Phase 4 Completed - United States, Utah ... More >> Salt Lake City, Utah, United States Less <<
NCT01089751 Overactive Bladder Phase 4 Completed - United States, California ... More >> La Mesa, California, United States Less <<
NCT03104101 Overactive Bladder Not Applicable Completed - -
NCT00932022 Obesity Overa... More >>ctive Bladder Incontinence Less << Phase 4 Completed - United States, California ... More >> La Mesa, California, United States Less <<
NCT00932022 - Completed - -
NCT01089751 - Completed - -
NCT00986401 Healthy Phase 1 Completed - United States, Arizona ... More >> Tempe, Arizona, United States Less <<
NCT00863551 Elderly Pharm... More >>acokinetics Overactive Bladder Less << Phase 4 Completed - United States, California ... More >> Glendale, California, United States Less <<
NCT00863551 - Completed - -
NCT03709992 Ureter Stone ... More >>Quality of Life Ureter Obstruction Less << Not Applicable Not yet recruiting November 1, 2019 -
NCT02831231 Schizophrenia Phase 1 Completed - United States, Ohio ... More >> Medpace Cincinnati, Ohio, United States, 45227 Less <<
NCT00986401 - Completed - -

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.34mL

0.47mL

0.23mL

11.68mL

2.34mL

1.17mL

23.37mL

4.67mL

2.34mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2
The prepared working fluid is recommended to be prepared now and used up as soon as possible in a short period of time. The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1

References

 

Historical Records

Categories